Willis-Knighton seeks participants for clinical trial investigating drug to treat COVID-19

Willis-Knighton Health System is seeking participants to be part of a clinical research study to determine whether a new drug made up of monoclonal antibodies shortens the symptoms of a COVID-19 infec…